We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 1.11 | 0.88% | 126.90 | 3,311,254 | 23:57:25 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 127.90 | 125.99 | 126.34 | |||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | DKK 232.26B | DKK 83.68B | DKK 18.5550 | 6.72 | 562.13B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 23:57:09 | 1 | 126.82 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 08/1/2024 | 13:45 | IHNW | Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs |
| 23/11/2023 | 18:56 | DJN | Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production.. |
| 15/11/2023 | 14:50 | DJN | Germany Could Consider Banning Ozempic Drug Export, Der Spiegel Reports |
| 13/11/2023 | 09:11 | DJN | Novo Nordisk's Wegovy Shows Heart Benefits Beyond Weight Loss, New Data.. |
| 10/11/2023 | 08:40 | DJN | Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity.. |
| 10/11/2023 | 07:24 | DJN | Novo Nordisk Invests Over $6 Billion to Boost Production Capacity |
| 02/11/2023 | 07:51 | DJN | Novo Nordisk Earnings Continue to Surge on Blockbuster Weight-Loss Drug.. |
| 02/11/2023 | 07:11 | DJN | Novo Nordisk Continues to Limit Supply of Blockbuster Weight-Loss Drug |
| 30/10/2023 | 12:45 | IHNW | Can Diabetes, Weight-Loss Drugs Get Even Better? |
| 20/10/2023 | 17:14 | DJN | Eli Lilly, Novo Nordisk Test Weight-Loss Shots in Younger Patients,.. |
Novo Nordisk (NVO) Share Charts1 Year Novo Nordisk Chart |
|
1 Month Novo Nordisk Chart |
Intraday Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
